ATSI Insider Trading Activity and SEC Form 4 Filings
ATSI insider trading summary
No open-market insider purchases or sales of Ats Medical Inc (ATSI) have been reported on SEC Form 4 in the past 12 months.
Latest ATSI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 1, 2010 | Astrid Marie Berthe | VP-Reg Affairs/Qual Assurance | Sell | $59K (14,900 @ $3.96) |
| Jun 30, 2010 | David R Elizondo | VP-Research & Development | Sell | $52K (13,125 @ $3.96) |
| Mar 16, 2010 | Thaddeus Coffindaffer | Vice President of Sales | Sell | $9K (3,580 @ $2.53) |
| Mar 16, 2010 | Astrid Marie Berthe | VP-Reg Affairs/Qual Assurance | Sell | $35K (13,970 @ $2.50) |
| Mar 16, 2010 | David R Elizondo | VP-Research & Development | Sell | $37K (14,760 @ $2.51) |
| Mar 16, 2010 | Craig A Swandal | Vice President of Operations | Sell | $13K (5,312 @ $2.50) |
| Mar 16, 2010 | Thaddeus Coffindaffer | Vice President of Sales | Sell | $13K (5,017 @ $2.53) |
| Mar 16, 2010 | Thaddeus Coffindaffer | Vice President of Sales | Sell | $12K (4,748 @ $2.53) |
| Mar 16, 2010 | Thaddeus Coffindaffer | Vice President of Sales | Sell | $3K (1,256 @ $2.53) |
| Mar 16, 2010 | Michael D Dale | Chief Executive Officer | Sell | $48K (19,300 @ $2.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.